← Open Payments lookup

ASSAH ASONGTIA: Open Payments

NPI 1144703216 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$714 in 41 payments from 8 companies in 2025. Trend: 2023 $247 · 2024 $646 · 2025 $714

Food & beverage: $714
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$268
Neurocrine BioSciences, Inc.4$120
Otsuka America Pharmaceutical, Inc.6$107
E.R. Squibb & Sons, L.L.C.4$74
Janssen Pharmaceuticals, Inc2$47
Alkermes, Inc.2$45
ABBVIE INC.2$37
Teva Pharmaceuticals USA, Inc.1$16

Products named: CAPLYTA, INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, VRAYLAR, LYBALVI, ARISTADA.

Industry payments across TX — which companies pay providers there.